Failure of one or both testes to descend into the scrotum by 6 months of age.
Also known as: cryptorchidism, undescended testis, UDT, undescended testicle
Overview
Failure of one or both testes to reach the dependent portion of the scrotum. Classified as palpable (in the inguinal canal or high scrotal position) or non-palpable (intra-abdominal, ectopic, or absent/vanishing testis).
Epidemiology
Present in ~3% of full-term and 30% of preterm male infants; most descend spontaneously by 3-6 months. Persistent cryptorchidism affects ~1% of boys at 1 year. Higher in low birth weight, prematurity, and twins.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Cryptorchidism (Undescended Testis) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Disorders of sex development (DSD) — especially if bilateral non-palpable
Pathophysiology
Testicular descent occurs in two phases: trans-abdominal (mediated by INSL3/RXFP2) and inguinoscrotal (androgen-dependent, mediated by genitofemoral nerve and CGRP). Disruption of either step results in cryptorchidism.
Clinical presentation
Symptoms
Usually asymptomatic; identified at newborn or well-child exam
Signs / physical exam
Inability to palpate the testis in the scrotum in a warm relaxed environment
Empty hemiscrotum (possibly hypoplastic)
Distinguish from retractile testis by warming the child and gentle manipulation
Differential diagnosis
Retractile testis — Hyperactive cremasteric reflex; testis can be manipulated into the scrotum and remains briefly — not cryptorchidism, no surgery needed but monitor (some become ascending testes)
Ascending testis (acquired UDT) — Previously fully descended testis later found out of the scrotum — managed similarly to congenital UDT with orchiopexy
Ectopic testis — Outside normal path of descent (perineal, femoral, contralateral scrotal); requires surgery
Anorchia / vanishing testis — Non-palpable unilateral testis; MIS and testosterone production absent on stimulation; confirmed at surgery
Diagnostic workup
Diagnostic criteria
Clinical examination — testis not present in the scrotum at >=6 months corrected age.
Anti-Mullerian hormone (AMH) and inhibin B levels can confirm presence or absence of functional testicular tissue (anorchia evaluation)
hCG stimulation test in select cases
Imaging
Routine ultrasound is NOT recommended (poor sensitivity and specificity, does not change management) per AUA
If non-palpable: diagnostic laparoscopy is the gold standard to locate or confirm absence of intra-abdominal testis
Diagnostic algorithm
flowchart TD
A[Newborn male, empty scrotum] --> B[Observe to 6 mo]
B --> C{Descended<br/>by 6 mo?}
C -->|Yes| D[Routine well-child care]
C -->|No| E[Refer to pediatric urology]
E --> F{Palpable?}
F -->|Yes| G[Inguinal orchiopexy<br/>between 6-18 mo]
F -->|No, unilateral| H[Diagnostic laparoscopy]
H -->|Intra-abdominal| I[Orchiopexy<br/>+/- Fowler-Stephens]
H -->|Absent / vanishing| J[Document, no further surgery]
F -->|No, bilateral| K[DSD workup<br/>karyotype, 17-OHP, AMH, hCG stim]
K --> H
Evaluation and management algorithm for cryptorchidism.
Treatment
First-line
Observation in first 6 months of life — most descend spontaneously
Orchiopexy between 6 and 18 months of age if testis has not descended (AUA recommends by 18 months; earlier surgery between 6-12 months may improve fertility and reduce malignancy risk)
Standard inguinal orchiopexy for palpable testis with hernia sac high ligation
Two-stage Fowler-Stephens orchiopexy for high intra-abdominal testes — first stage clipping of testicular vessels, second stage mobilization 6 months later
Hormonal therapy (hCG, GnRH) is NOT recommended by AUA — low efficacy and not durable
Post-pubertal / adult cryptorchidism
Orchiectomy generally recommended over orchiopexy after puberty due to higher malignancy risk and very low fertility potential in long-standing UDT
Bilateral post-pubertal cryptorchidism is managed individually, balancing testosterone production, fertility, and malignancy risk
Second-line / adjunct
Testicular prostheses may be offered after orchiectomy
Complications
Subfertility/infertility (greater in bilateral, intra-abdominal, and late-corrected cases)
Testicular germ cell cancer — RR ~2-8x for cryptorchid testes; orchiopexy reduces but does not eliminate risk and allows surveillance
Testicular torsion (cryptorchid testes are at increased risk)
Associated inguinal hernia (high incidence)
Psychological impact
PANCE pearls
Refer to pediatric urology by 6 months of age if testis has not descended — definitive surgery before 18 months reduces complications.
Imaging is NOT useful in cryptorchidism — diagnostic laparoscopy is the gold standard for non-palpable testes.
Bilateral non-palpable testes in a phenotypic male require urgent evaluation for disorder of sex development, including CAH (potentially virilized 46,XX female with salt-wasting crisis).
Orchiopexy reduces but does not eliminate testicular cancer risk; lifelong self-examination education is recommended.
A retractile testis is a normal variant and does not require surgery, but should be followed because a subset become ascending and require eventual repair.
References
AUA 2014 — AUA Guideline: Evaluation and Treatment of Cryptorchidism (Kolon et al., J Urol 2014)
EAU/ESPU — EAU/ESPU Guidelines on Paediatric Urology — Cryptorchidism
AAP — American Academy of Pediatrics Section on Urology resources
Practice Reproductive questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.